Shainur Premji

Shainur Premji

Auto-generated profile, based on publicly available information

Shainur Premji

Centre for Health Economics, University of York

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2024 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Open access
SMSheri Madigan
Sheri Madigan
Tracy VaillancourtTracy Vaillancourt
Tracy Vaillancourt
GDGina Dimitropoulos
Gina Dimitropoulos
SPShainur Premji
Shainur Premji
SKSelena M. Kahlert
Selena M. Kahlert
RNRoss Neville
Ross Neville
Conduct a meta-analysis documenting healthcare service utilization rates for pediatric (148,000 child and adolescent eating disorder-related visits to >300 health settings across 15 countries were included (mean age 12.7 [SD 4.1] years; 87% girls). There was strong evidence of an increase in healthcare utilization for EDs during the pandemic (rate ratio [RR] 1.54, 95%CI 1.38-1.71). Moderator analysis revealed larger rate increases among girls (RR 1.48, 95%CI 1.28-1.71) compared to boys (RR 1.24, 95%CI 1.06-1.45) and adolescents (≥12 to 19 years) (RR 1.53, 95%CI 1.29-1.81) compared to children (RR 0.87, 95%CI 0.53-1.43). Moderator analysis demonstrated strong evidence of increased utilization of emergency department (RR 1.70, 95%CI 1.48-1.97), inpatient (RR 1.56, 95%CI 1.33-1.84), and outpatient services (RR 1.62, 95%CI 1.35-1.95), as well as strong evidence of increased rates of anorexia nervosa (RR 1.48, 95%CI 1.24-1.75). Healthcare utilization for pediatric EDs increased substantially during the COVID-19 pandemic, particularly among girls and adolescents. It is important to continue to monitor if changes in healthcare utilization associated with acute pediatric mental distress are sustained beyond the COVID-19 pandemic.

27 May 2009 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
TCTimothy Caulfield
Timothy Caulfield
AZAmy Zarzeczny
Amy Zarzeczny
JMJennifer McCormick
Jennifer McCormick
TBTania Bubela
Tania Bubela
CCChristine Critchley
Christine Critchley
DWDavid E. Winickoff
David E. Winickoff

22 April 2009 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
EEEdna Einsiedel
Edna Einsiedel
SPShainur Premji
Shainur Premji
RGRose Geransar
Rose Geransar
NONoelle C. Orton
Noelle C. Orton
TTThushaanthini Thavaratnam
Thushaanthini Thavaratnam
LBLaura K. Bennett
Laura K. Bennett

1 February 2021 in Journal of Affective Disorders
Verified
Journal Article
Closed access
SPShainur Premji
Shainur Premji
SMSheila W. McDonald
Sheila W. McDonald
DMDeborah A. McNeil
Deborah A. McNeil
ESEldon Spackman
Eldon Spackman

1 June 2019 in Preventive Medicine Reports
Verified
Journal Article
Open access
SPShainur Premji
Shainur Premji
SMSheila W. McDonald
Sheila W. McDonald
AMAmy Metcalfe
Amy Metcalfe
PFPeter Faris
Peter Faris
HQHude Quan
Hude Quan
DMDeborah McNeil
Deborah McNeil
Affecting 10-15% of women, postpartum depression (PPD) can be debilitating and costly. While early identification has the potential to improve timely care, recommendations regarding the implementation of routine screening are inconsistent. In Alberta, screening is completed using the Edinburgh Postnatal Depression Scale during public health well child clinic visits. The objective of this study was to examine the effectiveness of screening in identifying, diagnosing and treating women at increased risk for PPD over the first year postpartum, compared to those unscreened. The All Our Families prospective pregnancy cohort was linked to public health, inpatient, outpatient, physician claims and community pharmaceutical data over the first year postpartum. Descriptive statistics and bivariate analyses examined differences in sample characteristics and PPD and non-PPD related utilization by screening category. Odds ratios and 95% confidence intervals for PPD diagnosis and mental health drugs dispensed were generated using crude and multivariable logistic regression models. Within our sample, 87% of the eligible population were screened, with 3% receiving a high-risk score, and 13% were unscreened. Compared to those unscreened, women screened high-risk had higher odds of being diagnosed with PPD (OR: 3.88, 95% CI: 2.18-6.92) and women screened low/moderate-risk had reduced odds of receiving a diagnosis (OR: 0.51, 95% CI: 0.35-0.74). High-risk women had an increased likelihood of diagnosis, higher PPD-related utilization and drugs dispensed compared to those unscreened. This information suggests that screening was effective at streamlining resources in Alberta. Future work should focus on evaluating the cost-effectiveness of PPD screening.

30 August 2019 in Developmental Medicine & Child Neurology
Verified
Journal Article
Open access
PDF file
MRMatthew J Russell
Matthew J Russell
SPShainur Premji
Shainur Premji
SMSheila Mcdonald
Sheila Mcdonald
JZJennifer Zwicker
Jennifer Zwicker
STSuzanne Tough
Suzanne Tough
Aim: This study examined children’s health care service use, mothers’ workforce participation, and mothers’ community engagement based on children’s risk of developmental delay.Method: We used data from the All Our Families study, a prospective pregnancy cohort. Ages and Stages Questionnaire (ASQ) scores at year 2 indicated risk of developmental delay. To investigate the impact of risk of developmental delay when children were not diagnosed, a sensitivity analysis excluded reports of neurodevelopmental disorder (NDD) diagnosis at year 3. Outcomes were maternal reports of children’s health and allied health visits (and estimated costs), and maternal workforce participation and community engagement from year 2 to 3.Results: Among 1314 mother–child dyads, 209 (16%) children were classified as being at risk of developmental delay by the ASQ, and 42 (3%) had a reported diagnosis of NDD. Risk of developmental delay was related to increased use of allied health care services (incidence risk ratio 5.04 [year 3]; 95% confidence interval 2.49–10.2) and health visits (incidence risk ratio 1.33 [year 3]; 95% confidence interval 1.14–1.54). The average expected allied health costs were greater for children at risk versus not at risk of developmental delay. However, when excluding children with reported diagnoses of an NDD from this analysis, increased service use and costs in the remaining at‐risk population were not observed. Community engagement and workplace participation among families did not differ on the basis of risk of developmental delay.Interpretation: These results suggest increased health care service use by families of children at risk of developmental delay is driven by those receiving a diagnosis of an NDD in the subsequent year.What this paper adds: Early developmental delay risk was related to health care service use and costs. Diagnosis of neurodevelopmental disorder drove increased health care service use and costs. Early developmental delay risk did not relate to parental workforce participation. Early developmental delay risk did not relate to community engagement participation.